ASGO 2019
"Optimal Gynecologic Cancer Care in Asia"
*Program is subject to change.
Time | Program | Speaker |
---|---|---|
[Special Session 3] International Research Collaboration through GCIG (90 min) | Chair: Kazunori Ochiai (Japan) Co-chair: Jae-Weon Kim (Korea) |
|
08:30-08:45 | Role of GCIG on changing the practice in gynecologic cancer patients | Keiichi Fujiwara (Japan) |
08:45-09:00 | Operation and harmonization for international clinical trial management | Yusuke Kajimoto (Japan) |
09:00-09:15 | Cervix & CCRN | Sang-Young Ryu (Korea) |
09:15-09:30 | Ovarian cancer | Rongyu Zang(China) |
09:30-09:45 | Endometrial cancer | Jae-Weon Kim (Korea) |
09:45-10:00 | Discussion | |
[Oral 5] TR & Hereditary (90 min) | Chair: Efren Domingo (Philippines) Co-chair: Dae-Hoon Jeong (Korea) |
|
08:30-08:40 | Development and preclinical testing of patient-derived xenograft(PDX) models for uterine cancer | Soo Young Jeong (Korea) |
08:40-08:50 | LncRNA RP11-395G23.3, as a competitive endogenous RNA, regulate PTEN expression by sponging miR-205-5p in the progression of endometrial cancer | Weijuan Xin (China) |
08:50-09:00 | Calcium channel CAV1.3 participates in epithelial-mesenchymal transition of endometrial cancer cells induced by transforming growth factor β | Yibo Dai (China) |
09:00-09:10 | Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers | Jeong-Won Lee (Korea) |
09:10-09:20 | Genomic comparison of endometrioid endometrial carcinoma and its precancerous lesions | Xuan Zong (China) |
09:20-09:30 | Clinicopathologic significance of mismatch repair protein expression in endometrial cancer | Mi-Kyung Kim (Korea) |
09:30-09:40 | Long term outcome of young patients with mismatch-repair deficient endometrial carcinoma | Mandy Man Yee Chu (Hong Kong) |
09:40-09:50 | Mutation landscape of germline and somatic BRCA1/2 genes in high-grade serous ovarian cancer patients | Kyung Jin Eoh (Korea) |
09:50-10:00 | Hormone replacement therapy after premature surgical menopause and health services utilization | Ji-Hyun Jang (Canada) |
[Poster Discussion] (20 min) | ||
08:30-08:50 | Selected poster discussion: merits and demerits | Yoo-Young Lee (Korea) |
[Education Session 5] Uterine and Cervical Cancer Surgery (60 min) | Chair: Ju Won Roh (Korea) Co-Chair: Joong Sub Choi (Korea) |
|
09:00-09:15 | Radical hysterectomy | Dae-Yeon Kim (Korea) |
09:15-09:30 | LEER | Hee-Seung Kim (Korea) |
09:30-09:45 | TMMR for cervical cancer | Rainer Kimmig (Germany) |
09:45-10:00 | PMMR for endometrial cancer | Rainer Kimmig (Germany) |
[Special Session 4] Clinical trial in Asia: Can We Make a Quantum Jump? (45 min) | Chair: Wen Yee Chay (Singapore) Co-chair: Jae-Hoon Kim (Korea) |
|
10:20-10:35 | Overview of the current status of clinical trials in Asia | Kosei Hasegawa (Japan) |
10:35-11:05 | Discussion | |
[Oral 6] Cervical Cancer & GTN Treatment (70 min) | Chair: Sang Hoon Kwon (Korea) Co-chair: Dong Choon Park (Korea) |
|
10:20-10:30 | Ovarian metastasis in early-stage cervical cancer: a large single institution study | Kittipat Charoenkwan (Thailand) |
10:30-10:40 | Impact of learning curve on the survival of abdominal or minimally invasive radical hysterectomy for early stage cervical cancer | Hwajung Lee (Korea) |
10:40-10:50 | Impact of obesity on clinical outcomes in patients with early-stage cervical cancer after radical hysterectomy with pelvic node dissection | Kittinun Leetanaporn (Thailand) |
10:50-11:00 | Post-irradiation PD-L1 expression predicts better prognosis after carbon ion radiotherapy in uterine cervical adenocarcinoma | Moito Iijima (Japan) |
11:00-11:10 | Comparisons of radiotherapy outcomes in cervical squamous cell carcinoma stage IIIB with and without lymph node enlargement | Fitriyadi Kusuma (Indonesia) |
11:10-11:20 | Clinical significance of centralized surveillance of hydatidiform mole: five years' experience from a regional hospital in China | Lan-zhou Jiao (China) |
11:20-11:30 | Gestational trophoblastic neoplasia: determinants of outcome | Seema Singhal (India) |
[Film 1A] (45 min) | Chair: Xiaohua Wu (China) Co-chair: Keun Ho Lee (Korea) |
|
10:20-10:29 | Nerve sparing modified laparoscopic radical hysterectomy with vaginal cuff closure and without uterine manipulator | Huaiwu Lu (China) |
10:29-10:38 | Clinical anatomy required in identifying pelvic autonomic nerve system | Yasuhiko Shiki (Japan) |
10:38-10:47 | Single-port laparoscopic radical trachelectomy with fluorescent image-guided sentinel lymph node dissection | Sang Wun Kim (Korea) |
10:47-10:56 | Robotic single-port surgical staging for endometrial cancer using da Vinci SP® surgical system | Jung Hun Lee (Korea) |
10:56-11:05 | Laparoscopic primary repair of duodenal perforation after laparoscopic para-aortic lymphadenectomy | Hyeon Myeong Hong (Korea) |
[Film 1B] (45 min) | Chair: Andri Andrijono (Indonesia) Co-chair: : Noh-Hyun Park (Korea) |
|
11:05-11:14 | Cervical cancer surgery | Zhengmao Zhang (China) |
11:14-11:23 | Laparoscopic extraperitoneal systematic pelvic and PARA-aortic lymphadenectomy | Supachai Raungkaewmanee (Thailand) |
11:23-11:32 | Laparoscopic extraperitoneal systematic pelvic and PARA-aortic lymphadenectomy | Dae-yeon Kim (Korea) |
11:32-11:41 | Single-site robotic staging surgery for early stage ovarian cancer | Ji Geun Yoo (Korea) |
11:41-11:50 | Combined technique of single-site robot and laparoscopy in comprehensive staging operation of endometrial cancer | Bo-Ra Lee (Korea) |
[Education Session 6] Training Session for Young Investigator and Research Nurse (50 min) | Chair: Rongyu Zang (China) Co-chair: Byoung-Gie Kim (Korea) |
|
11:10-11:25 | The Role of the CRC in an investigator initiated trial | Ju Yeon Yi (Korea) |
11:25-11:40 | The role and environment of research nurse | Noriko Fujiwara (Japan) |
11:40-11:55 | How to start investigator-initiated study? | Jung-Yun Lee (Korea) |
11:55-12:00 | Discussion | |
[Special Symposium 3] (20 min) | Chair: Sunghoon Kim (Korea) | |
12:10-12:30 | New PARP inhibitor in recurrent ovarian cancer, regardless of BRCA status: the role of niraparib | Aikou Okamoto (Japan) |
[Symposium 7] Fertility Preservation Upfront (60 min) | Chair: Jihong Liu (China) Co-chair: Kimio Ushijima (Japan) |
|
13:00-13:15 | Radical trachelectomy for young patients with early cervical cancer: the past and the future | Jin Li (China) |
13:15-13:30 | Fertility preserving treatment of early stage endometrial cancer | Xiaojun Chen (China) |
13:30-13:45 | Fertility preservation in early stage epithelial ovarian cancer | Hiroaki Kajiyama (Japan) |
13:45-14:00 | Fertility preservation for female cancer patients | Yutaka Osuga (Japan) |
[Education Session 7] Imaging in Ovarian Cancer Practice (60 min) | Chair: Jae Hong No (Korea) Co-chair: Seung-Su Han (Korea) |
|
13:00-13:15 | Imaging study before cytoreductive surgery | Byung Kwan Park (Korea) |
13:15-13:30 | Imaging follow up strategy of ovarian cancer | Jeong Yeon Cho (Korea) |
13:30-13:45 | Functional Imaging of ovarian cancer | Dae Chul Jung (Korea) |
13:45-14:00 | Response evaluation: RECIST & iRECIST on imaging | Sung Yoon Park (Korea) |
[Special Session 5] From Good Research to Good Publication (60 min) | Chair: Ki Hyung Kim (Korea) Co-chair: Chunling Chen (China) |
|
13:00-13:20 | Ethical review of the research project | Yawana Tanapat (Thailand) |
13:20-13:40 | Tips for success as a clinical investigator | Soyi Lim (Korea) |
13:40-14:00 | Transparency in medical writing | Seung-Hyuk Shim (Korea) |
[Symposium 8] Chemotherapy and Related Supportive Care (60 min) | Chair: Suresh Kumarasamy (Malaysia) Co-chair: Taejin Kim (Korea) |
|
14:05-14:20 | Post chemotherapy quality of life in developing country | Hariyono Winarto (Indonesia) |
14:20-14:35 | Hypersensitivity reactions to carboplatin and paclitaxel: management and oncologic outcomes |
Suwanit Therasakvichya (Thailand) |
14:35-14:50 | Hospice care by specialist palliative care team | Yoon Jung Chang (Korea) |
14:50-15:05 | Pain control in patients with advanced stage cancer | Seyoung Seo (Korea) |
[Oral 7] Medical Treatment in Ovarian Cancer (60 min) | Chair: Yong Jung Song (Korea) Co-chair: Kwang-Beom Lee (Korea) |
|
14:05-14:15 | Bevacizumab maintenance therapy extended the overall survival for the histopathological mesenchymal transition type of high-grade serous ovarian carcinoma | Kentaro Ishida (Japan) |
14:15-14:25 | Additional chemotherapy in epithelial ovarian cancer with residual disease after six cycles of postoperative adjuvant chemotherapy | Se Ik Kim (Korea) |
14:25-14:35 | Preliminary experience of hyperthermic intraperitoneal chemotherapy after debulking surgery for ovarian cancer | Wei-Chun Chen (Taiwan) |
14:35-14:45 | Enhanced chemotherapy effects on gynecological cancers by using the combination of lipid bubble and ultrasound | Kohei Yamaguchi (Japan) |
14:45-14:55 | Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: a promising drug delivery system for ovarian cancer | Hyeji Jeon (Korea) |
14:55-15:05 | The influence of depression on health utility value in patients with gynecologic cancer: a comparison with physical symptoms and performance status | Hyemin Yeo (Korea) |
[Education Session 8] Ovarian Cancer Surgery (60 min) | Chair: Chi-Heum Cho (Korea) Co-chair: Chih-Ming Ho (Taiwan) |
|
14:05-14:20 | Surgical technique : radical upper abdominal dissection/ resection | Suk-Joon Chang (Korea) |
14:20-14:35 | Surgical technique : radical pelvic dissection/ resection | Kazuyoshi Kato (Japan) |
14:35-14:50 | MSKCC resectability score and selection criteria for primary debulking surgery | Dennis Chi (USA) |
14:50-15:05 | Role of lymphadenectomy in ovarian cancer | Jianqing Zhu (China) |
15:05-15:20 | Closing Ceremony |